Thompson Coburn is pleased to announce that experienced health care attorney Daniel M. Tardiff has joined the Firm’s Health Care group. Dan joins the Firm following his tenure as the Chief Legal Counsel & Corporate Secretary for AllianceRx Walgreens Pharmacy, the nation’s third largest specialty and mail order pharmacy. He previously held roles in the Walgreen Co. legal department and, before that, was in private practice after beginning his career in the Civil Division of the U.S. Attorney’s Office for the Northern District of Illinois.
“Dan’s wealth of experience in the health care sector, his governmental enforcement background, and his role on the front lines with one of the country’s largest health care companies will provide invaluable assistance to our clients,” said Eric Tower, co-chair of Thompson Coburn’s Health Care group. “Dan brings to the table his in-house perspective and longtime collaborations with health care executives, skills and insights that will strengthen our group’s ability to provide streamlined, efficient services to health care entities of all types.”
“I look forward to joining Thompson Coburn’s national bench and bringing to bear the full range of my skills and cross-disciplinary experience, including working alongside senior leadership on a range of transactional and regulatory matters,” said Dan. “Thompson Coburn has a fantastic Health Care team, and I’m excited to collaborate with my new colleagues across the country for the benefit of our health care clients.”
In his role for AllianceRx Walgreens Pharmacy, Dan managed the delivery of legal, compliance, and privacy support and acted as the corporate governance advisor to the C-suite, board of directors and board committees, supporting strategic transactions and the growth of the company from start-up phase through maturity. He also has a successful record of managing, structuring, drafting, reviewing, negotiating and closing a wide variety of commercial transactions.
At Thompson Coburn, Dan will serve as a strategic thought partner who provides business-forward guidance in commercial transactions, health care regulatory matters, and pharmaceutical contracting, including procurement, rebates, and data reporting. He can also provide detailed guidance on reimbursement arrangements, corporate governance and board relations, strategy and innovation, litigation, and human resources matters, among other areas.
Dan is skilled at leading internal investigations into fraud, medical billing, and other compliance/privacy matters, and has counseled senior business leaders on how to manage consumer complaints and audits by payor and pharmaceutical clients, accreditation agencies, and federal and state regulatory agencies.
Dan started his legal career as an Assistant U.S. Attorney spending considerable time on civil health care and other fraud cases. During his time with the U.S. Attorney’s Office, Dan collaborated with numerous federal and state law enforcement agencies, including the FBI, numerous federal agency OIGs, the Illinois Attorney General’s Office and the Illinois State Police. He also tried several jury and bench trials and handled numerous appeals to the U.S. Court of Appeals.
Although we would like to hear from you, we cannot represent you until we know that doing so will not create a conflict of interest. Also, we cannot treat unsolicited information as confidential. Accordingly, please do not send us any information about any matter that may involve you until you receive a written statement from us that we represent you (an â€˜engagement letterâ€™).
By clicking the â€˜ACCEPTâ€™ button, you agree that we may review any information you transmit to us. You recognize that our review of your information, even if you submitted it in a good faith effort to retain us, and, further, even if you consider it confidential, does not preclude us from representing another client directly adverse to you, even in a matter where that information could and will be used against you. Please click the â€˜ACCEPTâ€™ button if you understand and accept the foregoing statement and wish to proceed.